
Despite the results of a large-scale trial, some experts questioned the use of beta-blockers for patients that suffered from heart failure and simultaneous AFib when in the presence of beta-adverse medications, like amiodarone.

Despite the results of a large-scale trial, some experts questioned the use of beta-blockers for patients that suffered from heart failure and simultaneous AFib when in the presence of beta-adverse medications, like amiodarone.

A study from the University of Warwick revealed a link between levels of gut hormone FGF-19 and diabetic remission in bariatric surgical patients.

Hybrid closed loop technology for CGM is available today; a contact lens may do the same thing soon. A look at 5 new diabetes tools.

Can we borrow elements of gaming apps to help patients better engage with their diabetes?





It's been a busy week in the world of public and private health care. Here's everything you need to know to stay connected.

High-amylose maize starch with chemical add-ons prevented diabtes in susceptible mice in an Australian study.

Plus a "Better Care Reconciliation Act" wrap up and 2 bonus approvals from across the pond.

The drug reduced cardiovascular risk in people with prior heart attack and inflammatory atherosclerosis.

Novo Nordisk seeks broad primary prevention claim, EMDAC recommends drug for patients with established CV.

Human antibody may substantially reduce need for insulin in patients with T1D.

ODYSSEY DM-DYSLIPIDEMIA is 1 of 2 studies on alirocumab presented at ADA Scientific Sessions.

Boys who are overweight as children but normalize as young adults have the same risk of type 2 diabetes as men who were never overweight.

More than 3,000 original research presentations will be offered in a robust 5-day program.

High HbA1c levels after the percutaneous cardiovascular intervention may help identify patients at long-term risk for adverse CV events.

Glioma is less common among diabetes patients.

Autism inked to maternal lifestyle, especially dietary factors impacting glucose.

Patients were randomized to standard care, nurse-led education intervention, or nurse-led education plus acceptance therapy.

Researcher calls it "some of the most exciting research in my career."

More than 25% of the US population over the age of 65 has diabetes.

